α-Synuclein activation of protein phosphatase 2A reduces tyrosine hydroxylase phosphorylation in dopaminergic cells
Abstract
α-Synuclein is an abundant presynaptic protein implicated in neuronal plasticity and neurodegenerative diseases. Although the function of α-synuclein is not thoroughly elucidated, we found that α-synuclein regulates dopamine synthesis by binding to and inhibiting tyrosine hydroxylase, the rate limiting enzyme in dopamine synthesis. Understanding α-synuclein function in dopaminergic cells should add to our knowledge of this key protein, which is implicated in Parkinson's disease and other disorders. Herein, we report a mechanism by which α-synuclein diminishes tyrosine hydroxylase phosphorylation and activity in stably transfected dopaminergic cells. Short-term regulation of tyrosine hydroxylase depends on the phosphorylation of key seryl residues in the amino-terminal regulatory domain of the protein. Of these, Ser40 contributes significantly to tyrosine hydroxylase activation and dopamine synthesis. We observed that α-synuclein overexpression caused reduced Ser40 phosphorylation in MN9D cells and inducible PC12 cells. Ser40 is phosphorylated chiefly by the cyclic AMP-dependent protein kinase PKA and dephosphorylated almost exclusively by the protein phosphatase, PP2A. Therefore, we measured the impact of α-synuclein overexpression on levels and activity of PKA and PP2A in our cells. PKA was unaffected by α-synuclein. PP2A protein levels also were unchanged, however, the activity of PP2A increased in parallel with α-synuclein expression. Inhibition of PP2A dramatically increased Ser40 phosphorylation only in α-synuclein overexpressors in which α-synuclein was also found to co-immunoprecipitate with PP2A. Together the data reveal a functional interaction between α-synuclein and PP2A that leads to PP2A activation and underscores a key role for α-synuclein in protein phosphorylation.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Soluble α-synuclein physically interacts with TH and maintains the level of phosphorylated TH in a PP2A-dependent manner.
“α-synuclein in the soluble form physically interacts with TH and maintains the level of phosphorylated TH in a PP2A-dependent manner [114,115,116]”
From Degradation of Tyrosine Hydroxylase by the Ubiquitin-Proteasome System in the Pathogenesis of Parkinson’s Disease and Dopa-Responsive Dystonia (2020) · cites this paper as [114]
Cites
Synuclein: a neuron-specific protein localized to the nucleus and presynaptic nerve terminal
Maroteaux, L., Campanelli, J., & Scheller, R. (1988) · Journal of Neuroscience · doi:10.1523/jneurosci.08-08-02804.1988 · Cited by 1,646 · cited 1× · see citing works
“α-Synuclein (α-Syn), a protein highly enriched in presynaptic terminals (Maroteaux et al., 1988), is implicated in normal brain function (George et al., 1989) as well as disease (reviewed by Perez and Hastings, 2004).”
BackgroundCeramide activates heterotrimeric protein phosphatase 2A
Dobrowsky, R. T., Kamibayashi, C., Mumby, M. C., & Hannun, Y. A. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)82288-8 · Cited by 666 · cited 2× · see citing works
“An active PP2A enzyme consists of a heterotrimer of the structural A subunit, a catalytic C subunit, and a regulatory B subunit (Dobrowsky et al., 1993).”
BackgroundProtein serine/threonine phosphatases: structure, regulation, and functions in cell growth
Mumby, M. C., & Walter, G. (1993) · Physiological Reviews · doi:10.1152/physrev.1993.73.4.673 · Cited by 661 · cited 2× · see citing works
“The A and C subunits are ubiquitously expressed (Mayer et al., 1991) and form the catalytic complex (PP2A/C), which interacts with at least three different families of regulatory B subunits, as well as with certain tumor antigens (Mumby and Walter, 1993).”
BackgroundA Role for α-Synuclein in the Regulation of Dopamine Biosynthesis
Perez, R. G., Waymire, J. C., Lin, E., Liu, J. J., Guo, F., & Zigmond, M. J. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-08-03090.2002 · Cited by 598 · cited 8× · see citing works
“Control MN9D cells with low endogenous levels of α-Syn, included both untransfected parental MN9D cells and MN9D cells stably transfected with either pcDNA3 or GFP vector (Perez et al., 2002).”
BackgroundInfluentialSelf-citationα-Synuclein Shares Physical and Functional Homology with 14-3-3 Proteins
Ostrerova, N., Petrucelli, L., Farrer, M. J., Mehta, N., Choi, P., Hardy, J., & Wolozin, B. L. (1999) · Journal of Neuroscience · doi:10.1523/jneurosci.19-14-05782.1999 · Cited by 560 · cited 5× · see citing works
“…protein 14-3-3 (Ostrerova et al., 1999), which binds to and regulates the activity of many cellular proteins. α-Syn interacts with and affects the activity of the enzymes phospholipase D (Ahn et al., 2002), protein kinase C and the extracellular regulated kinases (ERK) (Ostrerova et al., 1999).”
BackgroundInfluentialTyrosine hydroxylase phosphorylation: Regulation and consequences
Dunkley, P. R., Bobrovskaya, L., Graham, M. E., Von Nagy‐Felsobuki, E. I., & Dickson, P. W. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02797.x · Cited by 455 · cited 3× · see citing works
“Since it is well-documented that Ser40 dephosphorylation occurs almost exclusively by PP2A (Berresheim and Kuhn, 1994; Dunkley et al., 2004; Haavik et al., 1989; Leal et al., 2002) our findings indicate that (1) TH Ser40 is dephosphorylated by PP2A in dopaminergic cells, and (2) the Ser40 residue on TH remains accessi…”
BackgroundJenco, J. M., Rawlingson, A., Daniels, B., & Morris, A. J. (1998) · Biochemistry · doi:10.1021/bi972776r · Cited by 431 · cited 2× · see citing works
“…kinase mediating Ser40 phosphorylation and because α-Syn is so strongly implicated in enzymatic inhibition, e.g. ERK2, PLD2, TH (Iwata et al., 2001; Jenco et al., 1998; Perez et al., 2002) we first hypothesized that the reduction in TH Ser40 phosphorylation was probably occurring by α-Syn…”
BackgroundPerez, R. G., Soriano, S., Hayes, J. D., Ostaszewski, B. L., Xia, W., Selkoe, D. J., Chen, X., Stokin, G. B., & Koo, E. H. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.27.18851 · Cited by 387 · cited 1× · see citing works
“Cell lysates prepared in 1% NP40 buffer containing protease inhibitors were sonicated for ∼5 seconds and particulates were eliminated by centrifugation at 15,000 g for 10 minute at 4°C as previously described (Perez et al., 1999).”
MethodSelf-citationMcCright, B., Rivers, A. M., Audlin, S., & Virshup, D. M. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.36.22081 · Cited by 382 · cited 2× · see citing works
“…there is evidence that B subunits are associated with targeting the PP2A/C catalytic complexes to various intracellular sites such as microtubules (McCright et al., 1996; Sontag et al., 1995) and mitochondria (Ruvolo et al., 2002) suggesting that PP2A complexes are actively trafficked by their…”
BackgroundIchimura, T., Isobe, T., Okuyama, T., Takahashi, N., Araki, K., Kuwano, R., & Takahashi, Y. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.19.7084 · Cited by 339 · cited 4× · see citing works
“It is known that 14-3-3 can activate TH (Ichimura et al., 1988) by 14-3-3 binding first to TH Ser19 then to TH Ser40 (Kleppe et al., 2001).”
BackgroundInfluentialSontag, E., Nunbhakdi‐Craig, V., Bloom, G. S., & Mumby, M. C. (1995) · The Journal of Cell Biology · doi:10.1083/jcb.128.6.1131 · Cited by 301 · cited 2× · see citing works
“…B subunits are associated with targeting the PP2A/C catalytic complexes to various intracellular sites such as microtubules (McCright et al., 1996; Sontag et al., 1995) and mitochondria (Ruvolo et al., 2002) suggesting that PP2A complexes are actively trafficked by their associated interacting…”
BackgroundJOH, T. H., Park, D. H., & Reis, D. J. (1978) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.75.10.4744 · Cited by 284 · cited 2× · see citing works
“, 1993), it is the cAMP-dependent protein kinase PKA (Joh et al., 1978) that predominantly phosphorylates TH Ser40 in vivo (Campbell et al.”
BackgroundIdentification of four phosphorylation sites in the N-terminal region of tyrosine hydroxylase.
Campbell, D. G., Hardie, D. G., & Vulliet, P. R. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)67410-1 · Cited by 243 · cited 6× · see citing works
“…S ci en ce 3524 PKC (Albert et al., 1984; Vulliet et al., 1985), MSK-1 (Toska et al., 2002), MAPKAP kinases 1 and 2 (Sutherland et al., 1993), it is the cAMP-dependent protein kinase PKA (Joh et al., 1978) that predominantly phosphorylates TH Ser40 in vivo (Campbell et al., 1986; Wu et al., 1992).”
BackgroundInfluentialPhosphorylation of tyrosine hydroxylase in situ at serine 8, 19, 31, and 40.
Haycock, J. W. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)38451-0 · Cited by 224 · cited 1× · see citing works
“The regulation of TH activity in the short term depends on the phosphorylation of key seryl residues (Ser19, Ser31 and Ser40) in the amino-terminal regulatory domain (Campbell et al., 1986; Haycock, 1990).”
BackgroundIdentification of a New Family of Protein Phosphatase 2A Regulatory Subunits
McCright, B., & Virshup, D. M. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.44.26123 · Cited by 222 · cited 2× · see citing works
“The regulatory B subunits of PP2A are known to be temporally expressed during development (Csortos et al., 1996; Mayer et al., 1991; McCright and Virshup, 1995; Ruediger et al., 1991) and neuron-specific isoforms have also been identified (Mayer et al.”
BackgroundAlbert, K. A., Helmer-Matyjek, E., Nairn, A. C., Müller, T. H., Haycock, J. W., Greene, L. A., Goldstein, M., & Greengard, P. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.24.7713 · Cited by 219 · cited 2× · see citing works
“Jo ur na l o f C el l S ci en ce 3524 PKC (Albert et al., 1984; Vulliet et al., 1985), MSK-1 (Toska et al., 2002), MAPKAP kinases 1 and 2 (Sutherland et al., 1993), it is the cAMP-dependent protein kinase PKA (Joh et al., 1978) that predominantly phosphorylates TH Ser40 in vivo (Campbell et al.,…”
BackgroundTrojanowski, J. Q., & Lee, V. M. (1995) · The FASEB Journal · doi:10.1096/fasebj.9.15.8529836 · Cited by 216 · cited 2× · see citing works
“…PP2A may affect PP2A conformation or trafficking and subsequently contribute to its activation. α-Syn oxidative modification or aggregation occurs in neurodegenerative diseases such as Alzheimer’s disease, a condition in which PP2A is also implicated (Trojanowski and Lee, 1995; Zhao et al., 2003).”
BackgroundIdentities of Sequestered Proteins in Aggregates from Cells with Induced Polyglutamine Expression
Suhr, S. T., Senut, M., Whitelegge, J. P., Faull, K. F., Cuizon, D. B., & Gage, F. H. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.153.2.283 · Cited by 216 · see citing works
Mayer, R. E., Hendrix, P., Cron, P. D., Matthies, R., Stone, S. R., Goris, J., Merlevede, W. J., Hofsteenge, J., & Hemmings, B. A. (1991) · Biochemistry · doi:10.1021/bi00229a001 · Cited by 211 · cited 4× · see citing works
“, 1991) and neuron-specific isoforms have also been identified (Mayer et al., 1991).”
BackgroundInfluentialImmortalization of embryonic mesencephalic dopaminergic neurons by somatic cell fusion
Choi, H. K., Won, L., Kontur, P. J., Hammond, D. N., Fox, A. P., Wainer, B. H., Hoffmann, P. C., & Heller, A. (1991) · Brain Research · doi:10.1016/0006-8993(91)90661-e · Cited by 210 · cited 2× · see citing works
“The MN9D dopaminergic cells express abundant TH (Choi et al., 1991) and synthesize DA (Choi et al.”
BackgroundSutherland, C. D., ALTERIO, J., CAMPBELL, D. G., Bourdellès, B. L., Mallet, J. J., Haavik, J., & Cohen, P. (1993) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1993.tb18297.x · Cited by 177 · cited 2× · see citing works
“Jo ur na l o f C el l S ci en ce 3524 PKC (Albert et al., 1984; Vulliet et al., 1985), MSK-1 (Toska et al., 2002), MAPKAP kinases 1 and 2 (Sutherland et al., 1993), it is the cAMP-dependent protein kinase PKA (Joh et al., 1978) that predominantly phosphorylates TH Ser40 in vivo (Campbell et al.,…”
BackgroundHigh Complexity in the Expression of the B′ Subunit of Protein Phosphatase 2A0
Csoŕtos, C., Zołnierowicz, S., Bakó, É., Durbin, S. D., & DePaoli-Roach, A. A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.5.2578 · Cited by 163 · cited 4× · see citing works
“The substrate specificity of PP2A appears to be determined by the regulatory B subunits (Cegielska et al., 1994; Csortos et al., 1996) and there is evidence that B subunits are associated with targeting the PP2A/C catalytic complexes to various intracellular sites such as microtubules (McCright et…”
BackgroundInfluentialRuvolo, P. P., Clark, W., Mumby, M. C., Gao, F., & May, W. S. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201830200 · Cited by 153 · cited 2× · see citing works
“, 1995) and mitochondria (Ruvolo et al., 2002) suggesting that PP2A complexes are actively trafficked by their associated interacting proteins, one of which may be α-Syn.”
Backgroundα-Synuclein Affects the MAPK Pathway and Accelerates Cell Death
Iwata, A., Maruyama, M., Kanazawa, I., & Nukina, N. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m103736200 · Cited by 139 · cited 3× · see citing works
“ERK2, PLD2, TH (Iwata et al., 2001; Jenco et al., 1998; Perez et al., 2002) we first hypothesized that the reduction in TH Ser40 phosphorylation was probably occurring by α-Syn inhibition of PKA.”
BackgroundAhn, B., Rhim, H., Kim, S. Y., Sung, Y., Lee, M., Choi, J., Wolozin, B. L., Chang, J., Lee, Y. H., Kwon, T. K., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110414200 · Cited by 136 · cited 1× · see citing works
“…protein 14-3-3 (Ostrerova et al., 1999), which binds to and regulates the activity of many cellular proteins. α-Syn interacts with and affects the activity of the enzymes phospholipase D (Ahn et al., 2002), protein kinase C and the extracellular regulated kinases (ERK) (Ostrerova et al., 1999).”
BackgroundCould a loss of α‐synuclein function put dopaminergic neurons at risk?
Perez, R. G., & Hastings, T. G. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02423.x · Cited by 133 · cited 1× · see citing works
“α-Synuclein (α-Syn), a protein highly enriched in presynaptic terminals (Maroteaux et al., 1988), is implicated in normal brain function (George et al., 1989) as well as disease (reviewed by Perez and Hastings, 2004).”
BackgroundSelf-citationCegielska, A., Shaffer, S. A., Derua, R., Goris, J., & Virshup, D. M. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.7.4616 · Cited by 108 · see citing works
Haavik, J., Schelling, D. L., Campbell, D. G., Andersson, K. K., Flatmark, T., & Cohen, P. (1989) · FEBS Letters · doi:10.1016/0014-5793(89)81424-3 · Cited by 103 · cited 10× · see citing works
“, 2002), which reduces TH activity both in dopaminergic cells (Haavik et al., 1989) and in rat striatum (Bevilaqua et al.”
BackgroundMethodInfluentialCharacterization of the Active Site Iron in Tyrosine Hydroxylase
Ramsey, A., Hillas, P., & Fitzpatrick, P. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.40.24395 · Cited by 102 · cited 1× · see citing works
“Of these, phosphorylated Ser40 is a major contributor to DA synthesis in vivo (Ramsey et al., 1996).”
BackgroundSuhr, S. T., Gil, E. B., Senut, M., & Gage, F. H. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.14.7999 · Cited by 98 · cited 1× · see citing works
“These constructs form the basis of the ‘bomb system’ for inducible transgene expression (Suhr et al., 1998; Suhr et al., 2001) and were generously provided by Fred Gage and Steve Suhr at the Salk Institute (La Jolla, CA, USA).”
MethodChoi, H. K., Won, L., Roback, J. D., Wainer, B. H., & Heller, A. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.19.8943 · Cited by 96 · cited 1× · see citing works
“The MN9D dopaminergic cells express abundant TH (Choi et al., 1991) and synthesize DA (Choi et al., 1992).”
BackgroundVulliet, P. R., Woodgett, J. R., Ferrari, S. M., & Hardie, D. G. (1985) · FEBS Letters · doi:10.1016/0014-5793(85)80328-8 · Cited by 94 · cited 1× · see citing works
“Jo ur na l o f C el l S ci en ce 3524 PKC (Albert et al., 1984; Vulliet et al., 1985), MSK-1 (Toska et al., 2002), MAPKAP kinases 1 and 2 (Sutherland et al., 1993), it is the cAMP-dependent protein kinase PKA (Joh et al., 1978) that predominantly phosphorylates TH Ser40 in vivo (Campbell et al.,…”
BackgroundConstant Expression and Activity of Protein Phosphatase 2A in Synchronized Cells
Ruediger, R., Hood, J., Mumby, M. C., & Walter, G. (1991) · Molecular and Cellular Biology · doi:10.1128/mcb.11.8.4282-4285.1991 · Cited by 89 · cited 2× · see citing works
“The regulatory B subunits of PP2A are known to be temporally expressed during development (Csortos et al., 1996; Mayer et al., 1991; McCright and Virshup, 1995; Ruediger et al., 1991) and neuron-specific isoforms have also been identified (Mayer et al.”
BackgroundSynuclein‐1 is selectively up‐regulated in response to nerve growth factor treatment in PC12 cells
Stefanis, L., Kholodilov, N. G., Rideout, H. J., Burke, R. E., & Greene, L. A. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00114.x · Cited by 89 · cited 2× · see citing works
“Generation of stably transfected inducible PC12 cell lines α-Syn was cloned into pcDNA3 as previously described (Stefanis et al., 2001) followed by subcloning into the SKSP shuttle cloning vector using HindIII-XhoI.”
MethodSelf-citationUgarte, S. D., Lin, E., Klann, E., Zigmond, M. J., & Perez, R. G. (2003) · Journal of Neuroscience Research · doi:10.1002/jnr.10632 · Cited by 89 · cited 1× · see citing works
“Low-passage number MN9D cells were grown as previously described (Ugarte et al., 2003).”
MethodSelf-citationBegum, N., & Ragolia, L. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.49.31166 · Cited by 86 · cited 2× · see citing works
“2). α-Syn increases PP2A activity and binds to the PP2A catalytic domain We measured PP2A activity from the MN9D and induced PC12 cells using a well-established immunoprecipitation and phosphatase activity protocol (Begum and Ragolia, 1996).”
MethodPhosphorylation of Tyrosine Hydroxylase by Cyclic GMP‐Dependent Protein Kinase
Roskoski, R. J., Vulliet, P. R., & Glass, D. B. (1987) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1987.tb05593.x · Cited by 82 · cited 2× · see citing works
“Although multiple kinases can phosphorylate TH on Ser40 in vitro, including cyclic GMP-dependent protein kinase (Rodriguez-Pascual et al., 1999; Roskoski et al., 1987), CamKII (Campbell et al., 1986; Yamauchi and Fujisawa, 1981), 3523 α-Synuclein is an abundant presynaptic protein implicated in…”
BackgroundBevilaqua, L. R., Graham, M. E., Dunkley, P. R., von Nagy‐Felsobuki, E. I., & Dickson, P. W. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105280200 · Cited by 80 · cited 1× · see citing works
“There is additional evidence that the binding of 14-3-3 to TH phosphorylated on Ser19 and Ser40 stabilizes its conformation and enhances TH activity (Bevilaqua et al., 2001).”
BackgroundKleppe, R., Toska, K., & Haavik, J. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00318.x · Cited by 71 · cited 2× · see citing works
“It is known that 14-3-3 can activate TH (Ichimura et al., 1988) by 14-3-3 binding first to TH Ser19 then to TH Ser40 (Kleppe et al., 2001).”
BackgroundGarcia, L., Garcia, F., Llorens, F., Unzeta, M., Itarte, E., & Gómez, N. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)02950-2 · Cited by 48 · cited 2× · see citing works
“Furthermore, we treated cells with low to high dose okadaic acid (5 nM-1 μM) dissolved in DMSO (0.13 μM) (Garcia et al., 2002; Haavik et al., 1989) for 1 hour to assess the impact on PP2A inhibition in the presence of α-Syn overexpression and saw a similar effect.”
BackgroundMethodInfluentialGeorge, R. J., Haycock, J. W., Johnston, J. P., Craviso, G. L., & Waymire, J. C. (1989) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1989.tb10928.x · Cited by 39 · cited 2× · see citing works
“α-Synuclein (α-Syn), a protein highly enriched in presynaptic terminals (Maroteaux et al., 1988), is implicated in normal brain function (George et al., 1989) as well as disease (reviewed by Perez and Hastings, 2004).”
BackgroundSite-directed mutagenesis of tyrosine hydroxylase. Role of serine 40 in catalysis.
Wu, J., Filer, D., Friedhoff, A. J., & Goldstein, M. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)35673-4 · Cited by 38 · cited 2× · see citing works
“, 1978) that predominantly phosphorylates TH Ser40 in vivo (Campbell et al., 1986; Wu et al., 1992).”
BackgroundZhao, W., Feng, C., & Alkon, D. L. (2003) · Neurobiology of Disease · doi:10.1016/s0969-9961(03)00124-4 · Cited by 36 · cited 2× · see citing works
“…PP2A may affect PP2A conformation or trafficking and subsequently contribute to its activation. α-Syn oxidative modification or aggregation occurs in neurodegenerative diseases such as Alzheimer’s disease, a condition in which PP2A is also implicated (Trojanowski and Lee, 1995; Zhao et al., 2003).”
BackgroundYamauchi, T., & Fujisawa, H. (1981) · FEBS Letters · doi:10.1016/0014-5793(81)80769-7 · Cited by 36 · cited 1× · see citing works
“…Ser40 in vitro, including cyclic GMP-dependent protein kinase (Rodriguez-Pascual et al., 1999; Roskoski et al., 1987), CamKII (Campbell et al., 1986; Yamauchi and Fujisawa, 1981), 3523 α-Synuclein is an abundant presynaptic protein implicated in neuronal plasticity and neurodegenerative diseases.”
BackgroundTyrosine Hydroxylase Dephosphorylation by Protein Phosphatase 2A in Bovine Adrenal Chromaffin Cells
Leal, R. B., Sim, A. T. R., Gonçalves, C. A., & Dunkley, P. R. (2002) · Neurochemical Research · doi:10.1023/a:1014880403970 · Cited by 33 · cited 7× · see citing works
“It is well documented that dephosphorylation of TH Ser40 occurs almost exclusively by the phosphatase PP2A (Berresheim and Kuhn, 1994; Haavik et al., 1989; Leal et al., 2002), which reduces TH activity both in dopaminergic cells (Haavik et al.”
BackgroundInfluentialAddison, J. A. (1996) · Ecotoxicology and Environmental Safety · doi:10.1006/eesa.1996.0006 · Cited by 31 · cited 1× · see citing works
“Tebufenozide, which is a molt-inducing insecticide that mimics the action of ecdysone (Addison, 1996), was used for induction of α-Syn expression.”
MethodBevilaqua, L. R., Cammarota, M., Dickson, P. W., Sim, A. T. R., & Dunkley, P. R. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01792.x · Cited by 30 · cited 1× · see citing works
“It is well documented that dephosphorylation of TH Ser40 occurs almost exclusively by the phosphatase PP2A (Berresheim and Kuhn, 1994; Haavik et al., 1989; Leal et al., 2002), which reduces TH activity both in dopaminergic cells (Haavik et al., 1989) and in rat striatum (Bevilaqua et al., 2003).”
BackgroundRodríguez‐Pascual, F., Ferrero, R., Miras‐Portugal, M. T., & Torres, M. (1999) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1999.1199 · Cited by 28 · cited 2× · see citing works
“Although multiple kinases can phosphorylate TH on Ser40 in vitro, including cyclic GMP-dependent protein kinase (Rodriguez-Pascual et al., 1999; Roskoski et al., 1987), CamKII (Campbell et al., 1986; Yamauchi and Fujisawa, 1981), 3523 α-Synuclein is an abundant presynaptic protein implicated in…”
BackgroundBerresheim, U., & Kuhn, D. M. (1994) · Brain Research · doi:10.1016/0006-8993(94)91244-0 · Cited by 25 · cited 5× · see citing works
“Since it is well-documented that Ser40 dephosphorylation occurs almost exclusively by PP2A (Berresheim and Kuhn, 1994; Dunkley et al., 2004; Haavik et al., 1989; Leal et al., 2002) our findings indicate that (1) TH Ser40 is dephosphorylated by PP2A in dopaminergic cells, and (2) the Ser40 residue…”
BackgroundInfluentialPhosphorylation of Tyrosine Hydroxylase in Isolated Mice Adrenal Glands
Toska, K., Kleppe, R., Cohen, P., & Haavik, J. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04435.x · Cited by 16 · cited 3× · see citing works
“Jo ur na l o f C el l S ci en ce 3524 PKC (Albert et al., 1984; Vulliet et al., 1985), MSK-1 (Toska et al., 2002), MAPKAP kinases 1 and 2 (Sutherland et al., 1993), it is the cAMP-dependent protein kinase PKA (Joh et al., 1978) that predominantly phosphorylates TH Ser40 in vivo (Campbell et al.,…”
BackgroundDevelopmental Regulation of Protein Phosphatase Types 1 and 2A in Post-Hatch Chicken Brain
Sim, A. T. R., Collins, E., Mudge, L.-M., & Rostas, J. A. P. (1998) · Neurochemical Research · doi:10.1023/a:1022422332404 · Cited by 15 · cited 1× · see citing works
“Membrane bound PP2A in brain is reportedly less active (Sim et al., 1998), thus the interaction of PP2A with α-Syn within the cytosol may serve to stimulate PP2A activity.”
Background
Flagged first, then by citations
1 of the 52 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
-Synuclein in Parkinson's Disease
Stefanis, L. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a009399 · Cited by 1,446 · see citing works
“a-Synuclein is quite promiscuous in its binding properties, and may bind various proteins in neuronal cells, including components of dopamine metabolism, such as tyrosine hydroxylase (TH) and the dopamine transporter (DAT), modulating their function (Ostrerova et al. 1999; Perez et al. 2002; Wersinger and Sidhu 2003;…”
BackgroundSelf-citationα-Synuclein misfolding and Parkinson's disease
Breydo, L., Wu, J., & Uversky, V. N. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.10.002 · Cited by 656 · see citing works
“TBP-1 [332,333], phospholipase D [334], protein phosphatase 2A [335], DAT [336], mitochondrial complex IV enzyme cytochrome oxidase”
BackgroundCell Biology and Pathophysiology of α-SynucleinPreprint
Burré, J., Sharma, M., & Südhof, T. C. (2017) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a024091 · Cited by 576 · see citing works
The Synaptic Function of α-Synuclein
Burré, J. (2015) · Journal of Parkinson s Disease · doi:10.3233/jpd-150642 · Cited by 579 · see citing works
“-Synuclein inhibits dopamine synthesis by inhibiting the expression and activity of tyrosine hydroxylase [154, 168–170, 204], likely via reducing the phosphorylation state of tyrosine hydroxylase and stabilizing dephosphorylated inactive tyrosine hydroxylase [168, 205–207].”
BackgroundLarsen, K. E., Schmitz, Y., Troyer, M. D., Mosharov, E. V., Dietrich, P., Quazi, A. Z., Savalle, M., Nemani, V. M., Chaudhry, F. A., Edwards, R. H., et al. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.3821-06.2006 · Cited by 415 · see citing works
“…on effects of the protein on catecholamine synthesis, uptake, and vesicular accumulation (Lee et al., 2001; Lotharius et al., 2002; Perez et al., 2002; Wersinger et al., 2003; Peng et al., 2005), is that amount of transmitter released per vesicle fusion event (quantal size) might be decreased.”
BackgroundInfluentialSelf-citationMechanisms of α-Synuclein Induced Synaptopathy in Parkinson's Disease
Bridi, J. C., & Hirth, F. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00080 · Cited by 381 · see citing works
“Mechanistically, α-Syn decreases TH activity by reducing its phosphorylation in vitro (Perez et al., 2002; Peng et al., 2005) as TH is activated by phosphorylation of seryl residues in the TH regulatory domain (Alerte et al.”
BackgroundGorbatyuk, O. S., Li, S., Sullivan, L. F., Chen, W., Kondrikova, G., Manfredsson, F. P., Mandel, R. J., & Muzyczka, N. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711053105 · Cited by 294 · see citing works
“There is also evidence that -syn can modulate expression of genes involved in DA synthesis (11) and can affect enzymes involved in chromatin remodeling (12) and signal transduction (13).”
BackgroundAlpha-synuclein structure, functions, and interactions
Emamzadeh, F. N. (2016) · Journal of Research in Medical Sciences · doi:10.4103/1735-1995.181989 · Cited by 288 · see citing works
“Regulation of dopamine biosynthesis[45‐46] Protein phosphatase 2A Inhibition of tyrosine hydroxylase Regulation of dopamine levels”
BackgroundOxidative damage and the Nrf2-ARE pathway in neurodegenerative diseases
Gan, L., & Johnson, J. A. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.12.011 · Cited by 288 · see citing works
Yeger‐Lotem, E., Riva, L., Su, L. J., Gitler, A. D., Cashikar, A. G., King, O. D., Auluck, P. K., Geddie, M. L., Valastyan, J. S., Karger, D. R., et al. (2009) · Nature Genetics · doi:10.1038/ng.337 · Cited by 284 · see citing works
α-Synuclein and dopamine at the crossroads of Parkinson's disease
Venda, L. L., Cragg, S. J., Buchman, V. L., & Wade‐Martins, R. (2010) · Trends in Neurosciences · doi:10.1016/j.tins.2010.09.004 · Cited by 288 · see citing works
“In addition, α-synuclein has been shown to bind TH, preventing its phosphorylation and inhibiting its activation by promoting the activity of protein phosphatase 2A (PP2A) [35,40].”
BackgroundBenskey, M. J., Perez, R. G., & Manfredsson, F. P. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13570 · Cited by 247 · see citing works
Self-citationMolecular mechanisms of α-synuclein neurodegeneration
Waxman, E. A., & Giasson, B. I. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2008.09.013 · Cited by 241 · see citing works
“regulate the activity of several enzymes, including tyrosine hydroxylase, the rate-limiting enzyme in dopamine production [40,41],”
The role of alpha-synuclein in neurotransmission and synaptic plasticity
Cheng, F., Vivacqua, G., & Yu, S. (2010) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2010.12.001 · Cited by 238 · see citing works
“Several lines of evidence suggest that a-syn can reduce the phosphorylation of TH, bind with TH in a dephosphorylated state, and maintain TH in an inactive form (Perez et al., 2002; Peng et al., 2005; Wu et al., 2009; Lou et al., 2010).”
In Vivo RNAi-Mediated α-Synuclein Silencing Induces Nigrostriatal Degeneration
Gorbatyuk, O. S., Li, S., Nash, K. R., Gorbatyuk, M. S., Lewin, A. S., Sullivan, L. F., Mandel, R. J., Chen, W., Meyers, C., Manfredsson, F. P., et al. (2010) · Molecular Therapy · doi:10.1038/mt.2010.115 · Cited by 213 · see citing works
Anwar, S., Peters, O. M., Millership, S. J., Ninkina, N. N., Doig, N. M., Connor‐Robson, N., Threlfell, S., Kooner, G., Deacon, R. M. J., Bannerman, D. M., et al. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.6194-10.2011 · Cited by 200 · see citing works
“Much of the experimental evidence has, however, been obtained in vitro or in cultured cells (Jenco et al., 1998; Perez et al., 2002; Wersinger and Sidhu, 2003; Peng et al., 2005; Larsen et al., 2006; Tehranian et al., 2006; Fountaine et al., 2008; Liu et al., 2008), and similar roles have yet to be identified in the a…”
Backgroundα‐synuclein in the inner retina in parkinson disease
Bodis‐Wollner, I., Kozlowski, P. B., Glazman, S., & Miri, S. (2014) · Annals of Neurology · doi:10.1002/ana.24182 · Cited by 192 · see citing works
“The research literature suggests that AS staining in TH-positive neurons is problematic: the less TH immunoreactivity, the more AS antibody binds.(16,17) If that is correct, TH labeling is less in more advanced PD.”
BackgroundCell systems and the toxic mechanism(s) of α-synuclein
Cookson, M., & van der Brug, M. (2007) · Experimental Neurology · doi:10.1016/j.expneurol.2007.05.022 · Cited by 173 · see citing works
“, 2003; Wersinger and Sidhu, 2003) and the key DA synthesis enzyme, tyrosine hydroxylase (Peng et al., 2005; Perez et al., 2002).”
BackgroundJin, H., Kanthasamy, A., Ghosh, A., Yang, Y., Anantharam, V., & Kanthasamy, A. G. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.5634-10.2011 · Cited by 164 · see citing works
“The widely used N27 neuronal cell model represents a homogeneous population of TH-positive dopaminergic cells and is highly useful for studying degenerative mechanisms in PD (Clarkson et al., 1999; Kaul et al., 2005a; J. Peng et al., 2005; Zafar et al., 2007; Zhang et al., 2007a; Lee et al., 2009).”
BackgroundMethodInfluentialSenior, S. L., Ninkina, N. N., Deacon, R. M. J., Bannerman, D. M., Buchman, V. L., Cragg, S. J., & Wade‐Martins, R. (2008) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2008.06055.x · Cited by 164 · see citing works
“In tissue culture models, alpha-synuclein has been shown to inhibit DA synthesis by regulating the activity of tyrosine hydroxylase, protein phosphotase 2A, and aromatic amino acid decarboxylase (Perez et al., 2002; Peng et al., 2005; Tehranian et al., 2006).”
BackgroundThe association between Parkinson's disease and melanoma
Pan, T., Li, X., & Jankovic, J. J. (2011) · International Journal of Cancer · doi:10.1002/ijc.25912 · Cited by 155 · see citing works
A Synopsis on the Role of Tyrosine Hydroxylase in Parkinson’s Disease
Tabrez, S. S. M., Jabir, N. R., Shakil, S., Greig, N. H., Alam, Q., Abuzenadah, A. M., Damanhouri, G., & Kamal, M. A. (2012) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152712800792785 · Cited by 152 · see citing works
“This small and highly conserved protein is enriched in presynaptic terminals and is implicated in both normal as well as pathogenic brain function [60-64].”
BackgroundParkinson's disease: Alterations in iron and redox biology as a key to unlock therapeutic strategies
Ma, L., Azad, M. G., Dharmasivam, M., Richardson, V., Quinn, R. J., Feng, Y., Pountney, D. L., Tonissen, K. F., Mellick, G. D., Yanatori, I., et al. (2021) · Redox Biology · doi:10.1016/j.redox.2021.101896 · Cited by 148 · see citing works
“This is particularly apparent considering the effects of α-synuclein expression on tyrosine hydroxylase expression and activity [367,372,386].”
BackgroundNgwa, H. A., Kanthasamy, A., Gu, Y. H., Fang, N., Anantharam, V., & Kanthasamy, A. G. (2011) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2011.07.018 · Cited by 146 · see citing works
“Our lab and other research groups have used N27 cells extensively to study the neurotoxic mechanisms related to Parkinson's disease (Clarkson et al., 1999; Miranda et al., 2004; Kaul et al., 2005; Peng et al., 2005; Kanthasamy et al., 2006).”
Backgroundα-Synuclein Expression Modulates Microglial Activation Phenotype
Austin, S. A., Floden, A. M., Murphy, E. J., & Combs, C. K. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.1799-06.2006 · Cited by 142 · see citing works
“-Synuclein binds a variety of proteins (Jenco et al., 1998; Peng et al., 2005) and lipid vesicles (Cole et al.”
BackgroundTuon, T., Valvassori, S. S., Lopes-Borges, J., Luciano, T. F., Tromm, C. B., da Silva, L. A., Quevedo, J., de Souza, C. T., Lira, F. S., & Pinho, R. A. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.09.063 · Cited by 139 · see citing works
“It is possible that decreased levels of TH can also be associated with the observed increase in the level of a-synuclein, because the a-synuclein has easy interactions between with TH, thus reducing its phosphorylation (Peng et al., 2005).”
The Central Theme of Parkinson’s Disease: α-Synuclein
Ozansoy, M., & Başak, A. N. (2012) · Molecular Neurobiology · doi:10.1007/s12035-012-8369-3 · Cited by 137 · see citing works
“Dopamine reduction is observed with the decrease in TH and dopamine transporter expressions [18, 20–24].”
BackgroundModels of α-synuclein aggregation in Parkinson’s disease
Giráldez‐Pérez, R. M., Antolín‐Vallespín, M., Muñoz, M.-D., & Sánchez‐Capelo, A. (2014) · Acta Neuropathologica Communications · doi:10.1186/s40478-014-0176-9 · Cited by 134 · see citing works
“It is known that α-syn inhibits tyrosine hydroxylase, the rate limiting enzyme of DA biosynthesis [163,164], and aromatic amino acid decarboxylase, the enzyme that converts L-Dopa to DA [165].”
BackgroundViral vector-mediated overexpression of α-synuclein as a progressive model of Parkinson’s disease
Ulusoy, A., Decressac, M., Kirik, D., & Björklund, A. (2010) · Progress in brain research · doi:10.1016/s0079-6123(10)84005-1 · Cited by 130 · see citing works
“There is considerable evidence that the expression of PP2A, while the activity of the phosphatase is increased in parallel with a-syn expression (Peng et al., 2005; Perez et al., 2002).”
BackgroundTejeda, G., & Díaz-Guerra, M. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18020268 · Cited by 126 · see citing works
“Thus, elevated levels of α-synuclein increase the activity of the Akt inhibitors phosphatase PP2A [135] and RTP801 [136] while Akt phosphorylation is significantly diminished in dopaminergic SN neurons of PD patients [137].”
BackgroundComplex molecular regulation of tyrosine hydroxylase
Tekin, I., Roskoski, R., Carkaci-Salli, N., & Vrana, K. E. (2014) · Journal of Neural Transmission · doi:10.1007/s00702-014-1238-7 · Cited by 128 · see citing works
Prion-Like Mechanisms in Parkinson’s Disease
Ma, J., Gao, J., Wang, J., & Xie, A. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00552 · Cited by 124 · see citing works
“It was also confirmed that α-syn significantly reduced AADC activity and phosphorylation in cells (Perez et al., 2002; Peng et al., 2005; Tehranian et al., 2006).”
The Role of Cholesterol in α‐Synuclein and Lewy Body Pathology in GBA1 Parkinson's Disease
García‐Sanz, P., Aerts, J. M. F. G., & Moratalla, R. (2020) · Movement Disorders · doi:10.1002/mds.28396 · Cited by 124 · see citing works
The protective role of AMP-activated protein kinase in alpha-synuclein neurotoxicity in vitro
Dulović, M., Jovanović, M., Xilouri, M., Stefanis, L., Harhaji-Trajkovic, L. M., Kravic‐Stevovic, T., Paunović, V., Ardah, M. T., El‐Agnaf, O. M. A., Kostić, V., et al. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2013.11.002 · Cited by 123 · see citing works
Self-citationLou, H., Montoya, S. E., Alerte, T. N. M., Wang, J., Wu, J., Peng, X., Hong, C.-S., Friedrich, E. E., Mader, S. A., Pedersen, C. J., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.100867 · Cited by 115 · see citing works
Self-citationThe Role of Alpha-Synuclein in Melanin Synthesis in Melanoma and Dopaminergic Neuronal Cells
Pan, T., Zhu, J. X., Hwu, W., & Jankovic, J. J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045183 · Cited by 115 · see citing works
Alpha‐synuclein inhibits aromatic amino acid decarboxylase activity in dopaminergic cells
Tehranian, R., Montoya, S. E., Laar, A. D. V., Hastings, T. G., & Perez, R. G. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04146.x · Cited by 114 · see citing works
“All steps were carried out at 4 C as described by Peng et al. (2005), but with minor modifications.”
BackgroundMethodInfluentialSelf-citationα-Synuclein and Its A30P Mutant Affect Actin Cytoskeletal Structure and Dynamics
Sousa, V. L., Bellani, S., Giannandrea, M., Yousuf, M., Valtorta, F., Meldolesi, J., & Chieregatti, E. (2009) · Molecular Biology of the Cell · doi:10.1091/mbc.e08-03-0302 · Cited by 112 · see citing works
“Recently -synuclein has been shown to activate the protein phosphatase 2A (Peng et al., 2005), a phosphatase involved in actin dephosphorylation.”
BackgroundAlza, N. P., González, P. A. I., Conde, M. A., Uranga, R. M., & Salvador, G. A. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00175 · Cited by 111 · see citing works
“…of dopamine levels by α-synuclein has been demonstrated as a consequence of the inhibition of the neurotransmitter synthesis through the regulation of tyrosine hydroxylase activity (Abeliovich et al., 2000; Peng, 2005) and the inhibition of the vesicular monoamine transporter-2 (Guo et al., 2008).”
BackgroundParkinson’s Disease and Melanoma: Co-Occurrence and Mechanisms
Bose, A., Petsko, G. A., & Eliezer, D. (2018) · Journal of Parkinson s Disease · doi:10.3233/jpd-171263 · Cited by 111 · see citing works
Molecular crosstalk between cancer and neurodegenerative diseases
Seo, J., & Park, M. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03428-3 · Cited by 106 · see citing works
Parkinson's Disease-Related Protein, α-Synuclein, in Malignant Melanoma
Matsuo, Y., & Kamitani, T. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010481 · Cited by 108 · see citing works
“In these cells, a-synuclein may inhibit the activity of tyrosine hydroxylase [16,17] and affect melanin production as described previously [18,19].”
BackgroundZhang, D., Kanthasamy, A., Yang, Y., Anantharam, V., & Kanthasamy, A. G. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.4107-06.2007 · Cited by 103 · see citing works
“Therefore, in the dopaminergic system, the physical and functional association between PKC , TH, and PP2A could be facilitated and/or regulated by chaperone proteins such as -synuclein (Kaul et al., 2005; Peng et al., 2005) and 14-3-3 (Ostrerova et al.”
BackgroundResultBenskey, M. J., Sellnow, R. C., Sandoval, I. M., Sortwell, C. E., Lipton, J. W., & Manfredsson, F. P. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00036 · Cited by 102 · see citing works
“…the result of disinhibition of TH following αsyn knockdown. α-syn acts as a negative regulator of both TH and aromatic amino acid decarboxylase (AADC; Perez et al., 2002; Perez and Hastings, 2004; Yu et al., 2004; Peng et al., 2005; Tehranian et al., 2006; Wang et al., 2009; Benskey et al., 2016a).”
BackgroundThe remarkable conformational plasticity of alpha-synuclein: blessing or curse?
Deleersnijder, A., Gérard, M., Debyser, Z., & Baekelandt, V. (2013) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2013.04.002 · Cited by 101 · see citing works
Loss of Functional Alpha-Synuclein: A Toxic Event in Parkinson's Disease?
Kanaan, N. M., & Manfredsson, F. P. (2012) · Journal of Parkinson s Disease · doi:10.3233/jpd-012138 · Cited by 99 · see citing works
Alerte, T. N. M., Akinfolarin, A. A., Friedrich, E. E., Mader, S. A., Hong, C.-S., & Perez, R. G. (2008) · Neuroscience Letters · doi:10.1016/j.neulet.2008.02.014 · Cited by 98 · see citing works
“Previously, we noted that α-Syn acts to inhibit TH phosphorylation and dopamine synthesis in vitro [31,33].”
BackgroundMethodInfluentialSelf-citationImmunological features of α‐synuclein in Parkinson's disease
Roodveldt, C., Christodoulou, J. C., & Dobson, C. M. (2008) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00450.x · Cited by 95 · see citing works
“It is known to interact with a variety of proteins [13, 14] and also with lipid vesicles [15], and it may be involved in lipid metabolism [16, 17].”
BackgroundMitochondrial Dysfunction: The Road to Alpha-Synuclein Oligomerization in PD
Esteves, A. R., Arduíno, D. M., Silva, D. F., Oliveira, C. R., & Cardoso, S. M. (2011) · Parkinson s Disease · doi:10.4061/2011/693761 · Cited by 89 · see citing works
“It is thought that alpha-syn plays a role in the regulation of dopamine biosynthesis via activation of protein phosphatase 2A that reduces tyrosine hydroxylase phosphorylation, the rate-limiting enzyme in dopamine production [158, 159], and reducing the amount of available active mitogen-activated protein kinases [160…”
α-Synuclein binds the KATP channel at insulin-secretory granules and inhibits insulin secretion
Geng, X., Lou, H., Wang, J., Li, L., Swanson, A., Sun, M., Beers-Stolz, D., Watkins, S. C., Perez, R. G., & Drain, P. F. (2010) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00262.2010 · Cited by 90 · see citing works
“All steps were carried out at 4°C as previously described (46, 47), with minor modifications.”
BackgroundMethodSelf-citationPrasanthi, J. R. P., Feist, G., Thomasson, S., Thompson, A. J., Schommer, E., & Ghribi, O. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05736.x · Cited by 88 · see citing works
RetractedManzanza, N. D. O., Sedlackova, L., & Kalaria, R. N. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.690293 · Cited by 89 · see citing works
“…et al., 2015; Sharma et al., 2015 Regulation of DA biosynthesis Protein phosphatase 2A Inhibition of tyrosine Hydroxylase Regulation of DA levels Peng et al., 2005; Yang et al., 2013 Suppression of apoptosis Protein C Kinase Deactivation of NFkB Neuroprotection Jin et al., 2011 SNARE,…”
BackgroundTyrosine hydroxylase phosphorylation in vivo
Dunkley, P. R., & Dickson, P. W. (2019) · Journal of Neurochemistry · doi:10.1111/jnc.14675 · Cited by 85 · see citing works
“The decreases in TH phosphorylation at Ser40 are not because of decreases in PKA activity, but rather to increases in PP2A activity (Peng et al. 2005).”
BackgroundInfluentialDynamic structural flexibility of α-synuclein
Mor, D. E., Ugras, S. E., Daniels, M. J., & Ischiropoulos, H. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2015.12.018 · Cited by 82 · see citing works
α-Synuclein transgenic mice exhibit reduced anxiety-like behaviour
George, S., van den Buuse, M., Mok, S. S., Masters, C. L., Li, Q., & Culvenor, J. G. (2008) · Experimental Neurology · doi:10.1016/j.expneurol.2007.12.017 · Cited by 84 · see citing works
Alpha-synuclein modulates dopamine neurotransmission
Butler, B., Sambo, D. O., & Khoshbouei, H. (2016) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2016.06.001 · Cited by 71 · see citing works
Marwarha, G., Rhen, T., Schommer, T., & Ghribi, O. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07497.x · Cited by 82 · see citing works
“(2011) 119, 1119–1136 1119 well as decreased TH expression (Yu et al. 2004; Gao et al. 2007) and activity (Perez et al. 2002; Peng et al. 2005).”
RetractedLuo, J., Sun, L., Lin, X., Liu, G., Yu, J., Parisiadou, L., Xie, C., Ding, J., & Cai, H. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu377 · Cited by 79 · see citing works
Post, M. R., Lieberman, O. J., & Mosharov, E. V. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00161 · Cited by 79 · see citing works
“, 2010), which was modulated by the activity of protein phosphatase 2A (Peng et al., 2005).”
BackgroundLee, K., Im, J., Woo, J. J., Jasutkar, H. G., Kim, Y., Cristóvão, A. C., Sonsalla, P. K., Schuster, D. S., Jalbut, M. M., Fernández, J. R., et al. (2013) · Neurotherapeutics · doi:10.1007/s13311-012-0165-2 · Cited by 78 · see citing works
“Additionally, normalization of PP2A function has been hypothesized to be relevant in relation to modulation of tyrosine hydroxylase function [37, 38].”
Background14-3-3ζ Contributes to Tyrosine Hydroxylase Activity in MN9D Cells
Wang, J., Lou, H., Pedersen, C. J., Smith, A. D., & Perez, R. G. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m901310200 · Cited by 75 · see citing works
Self-citationKawahata, I., & Fukunaga, K. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21113779 · Cited by 71 · see citing works
Involvement of ERK1/2 signaling pathway in DJ-1-induced neuroprotection against oxidative stress
Gu, L., Cui, T., Fan, C., Zhao, H., Zhao, C., Lu, L., & Yang, H. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.04.037 · Cited by 74 · see citing works
“a-Synuclein was found to co-immunoprecipitate with PP2A [22] and we found that the expression of PP2A was modulated by a-synuclein (data not shown).”
BackgroundThe role of lipids in α-synuclein misfolding and neurotoxicity
Ugalde, C. L., Lawson, V., Finkelstein, D. I., & Hill, A. F. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.rev119.007500 · Cited by 72 · see citing works
Zhang, S., Yu, Z., Xia, J., Zhang, X., Liu, K., Attila Gabor, S. I. K., & Jin, M. (2019) · Food & Function · doi:10.1039/c9fo02288k · Cited by 72 · see citing works
FTY720/Fingolimod Reduces Synucleinopathy and Improves Gut Motility in A53T Mice
Vidal-Martínez, G., Vargas‐Medrano, J., Gil-Tommee, C., Medina, D. X., Garza, N. T., Yang, B. C., Segura‐Ulate, I., Dominguez, S. J., & Perez, R. G. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.744029 · Cited by 72 · see citing works
Self-citationDynamics of tyrosine hydroxylase mediated regulation of dopamine synthesis
Kaushik, P., Gorin, F. A., & Vali, S. (2006) · Journal of Computational Neuroscience · doi:10.1007/s10827-006-0004-8 · Cited by 74 · see citing works
Alpha-Synuclein Contribution to Neuronal and Glial Damage in Parkinson’s Disease
Saramowicz, K., Siwecka, N., Galita, G., Kucharska-Lusina, A., Rozpędek‐Kamińska, W., & Majsterek, I. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms25010360 · Cited by 76 · see citing works
“In vitro studies have shown that α Syn overexpression leads to downregulation of crucial enzymes involved in DA biosynthesis (tyrosine hydroxylase and aromatic amino acid decarboxylase), as well as an impairment of dopamine transporter (DAT) reuptake activity [125–127].”
A new role for α‐synuclein in Parkinson's disease: Alteration of ER–mitochondrial communication
Guardia‐Laguarta, C., Área-Gómez, E., Schon, E. A., & Przedborski, S. (2015) · Movement Disorders · doi:10.1002/mds.26239 · Cited by 70 · see citing works
“Given that a-Syn associates with PP2A,(115) perhaps the phosphorylation status of both proteins is mediated in a reciprocal way, via PP2A, a possibility proposed by others.(58,115,117,119) What connection might there be among the phosphorylation of a-Syn, TH activity, PP2A activity, and MAM? First, we propose that the…”
BackgroundLue, L., Walker, D. G., Adler, C., Shill, H. A., Tran, H., Akiyama, H., Sue, L., Caviness, J., Sabbagh, M. N., & Beach, T. G. (2012) · Brain Pathology · doi:10.1111/j.1750-3639.2012.00585.x · Cited by 65 · see citing works
“By inhibition of the enzyme that dephosphorylates TH, called phosphor-protein phosphatase 2A (PP2A), asyn promotes the activity of the TH (47).”
BackgroundLRRK2 Phosphorylation, More Than an Epiphenomenon
Marchand, A., Drouyer, M., Sarchione, A., Chartier‐Harlin, M., & Taymans, J. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00527 · Cited by 70 · see citing works
“…| www.frontiersin.org 13 June 2020 | Volume 14 | Article 527 (Reynolds et al., 2014) without affecting the protein level of PP2A in cell lines (Peng et al., 2005), but on the other hand, increased oligomerization and phosphorylation of α-syn reduced the activity of PP2A (Lou et al., 2010;…”
BackgroundAkt as a Victim, Villain and Potential Hero in Parkinson’s Disease Pathophysiology and Treatment
Greene, L. A., Levy, O., & Malagelada, C. (2011) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-011-9671-8 · Cited by 68 · see citing works
“Of relevance to this, the activity/level of protein phosphatase 2A (PP2A), for which phospho-Akt is a substrate, is elevated by alpha synuclein (Peng et al. 2005) and in response to 6-OHDA (Ryu et al. 2005; Chung et al. 2007) in cultured cells.”
Hu, Z., Chen, B., Zhang, J., & Ma, Y. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.764795 · Cited by 68 · see citing works
Intrinsically disordered proteins may escape unwanted interactions via functional misfolding
Uversky, V. N. (2011) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2011.03.010 · Cited by 65 · see citing works
Farrell, K., Krishnamachari, S., Villanueva, E., Lou, H., Alerte, T. N. M., Peet, E., Drolet, R. E., & Perez, R. G. (2013) · Journal of Neurochemistry · doi:10.1111/jnc.12481 · Cited by 63 · see citing works
“Inhibitors for specificity included: 50 nM protein-phosphataseinhibitor 2 (PP1-specific), 3 nM fostriecin (PP2A/PP4-specific), 50 nM cantharidin (PP4-specific), and 10 nM okadaic acid as previously described (Peng et al. 2005; Lou et al. 2010; Wu et al. 2012).”
InfluentialSelf-citationSalvatore, M. F., & Pruett, B. S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0029867 · Cited by 61 · see citing works
“Thus, pharmacological agents such as antipsychotics [12,33] or neuropathological events [27,34–37]”
Silencing α-Synuclein Gene Expression Enhances Tyrosine Hydroxylase Activity in MN9D Cells
Liu, D., Jin, L., Wang, H., Zhao, H., Zhao, C., Duan, C., Lu, L., Wu, B., Yu, S., Chan, P., et al. (2008) · Neurochemical Research · doi:10.1007/s11064-008-9599-7 · Cited by 61 · see citing works
The interaction of α-synuclein and Tau: A molecular conspiracy in neurodegeneration?
Xu, Y., Uronen, R., & Huttunen, H. J. (2018) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2018.05.005 · Cited by 61 · see citing works
Lewy-like aggregation of α-synuclein reduces protein phosphatase 2A activity in vitro and in vivo
Wu, J., Lou, H., Alerte, T. N. M., Stachowski, E. K., Chen, J., Singleton, A., Hamilton, R. L., & Perez, R. G. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.01.028 · Cited by 58 · see citing works
“While α-Syn and the catalytic subunit of PP2A are known to interact (Peng et al., 2005), no one knows if α-Syn might also bind B subunits of PP2A to in some manner contribute to holoenzyme assembly or localization.”
BackgroundInfluentialSelf-citationDysregulated dopamine storage increases the vulnerability to α-synuclein in nigral neurons
Ulusoy, A., Björklund, T., Buck, K., & Kirik, D. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2012.05.012 · Cited by 57 · see citing works
“…hydroxylase (TH), DA transporter (DAT) and vesicular monoamine transporter-2 (VMAT2) function, aromatic amino acid decarboxylase and tetrahydrobiopterin (co-factor essential for TH function) (Baptista et al., 2003; Lee et al., 2001; Peng et al., 2005; Perez et al., 2002; Tehranian et al., 2006).”
BackgroundVecchio, L. M., Sullivan, P., Dunn, A. R., Bermejo, M. K., Fu, R., Masoud, S. T., Gregersen, E., Urs, N. M., Nazari, R., Jensen, P. H., et al. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15432 · Cited by 56 · see citing works
“Protein phosphatase 2A (PP2A) is the main phosphatase responsible for dephosphorylating TH and regulating its activity (Haavik et al. 1989; Peng et al. 2005).”
BackgroundInfluentialRole of Apolipoproteins and α-Synuclein in Parkinson’s Disease
Emamzadeh, F. N. (2017) · Journal of Molecular Neuroscience · doi:10.1007/s12031-017-0942-9 · Cited by 54 · see citing works
“leading to deactivation of TH and reduction of dopamine levels (Peng et al. 2005; Lou et al. 2010).”
BackgroundExercise does not protect against MPTP-induced neurotoxicity in BDNF happloinsufficent mice
Gerecke, K. M., Jiao, Y., Pagala, V., & Smeyne, R. J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0043250 · Cited by 53 · see citing works
“and alpha-synuclein aggregation; both critical to the neuropathology of Parkinson’s disease [106–109].”
BackgroundLinking Parkinson's Disease and Melanoma: Interplay Between α‐Synuclein and Pmel17 Amyloid Formation
Dean, D. N., & Lee, J. C. (2021) · Movement Disorders · doi:10.1002/mds.28655 · Cited by 52 · see citing works
“α-Syn Disrupts Tyrosine Hydroxylase and/or Tyrosinase Activity The prevailing hypothesis(26,32-34,37,39) to describe the inverse correlation between α-syn expression and melanin production states that α-syn disrupts the activities of catalytic enzymes involved in melanin biosynthesis, namely, tyrosine hydroxylase (TH)…”
BackgroundGorbatyuk, O. S., Li, S., Nguyen, F. N., Manfredsson, F. P., Kondrikova, G., Sullivan, L. F., Meyers, C., Chen, W., Mandel, R. J., & Muzyczka, N. (2010) · Molecular Therapy · doi:10.1038/mt.2010.137 · Cited by 52 · see citing works
Neurons and Glia Interplay in α-Synucleinopathies
Mavroeidi, P., & Xilouri, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094994 · Cited by 52 · see citing works
Wilkaniec, A., Cieślik, M., Murawska, E., Babiec, L., Gąssowska-Dobrowolska, M., Pałasz, E., Jęśko, H. M., & Adamczyk, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21113959 · Cited by 50 · see citing works
Expression and Subcellular Location of Alpha-Synuclein During Mouse-Embryonic Development
Zhong, S., Luo, X. G., Chen, X.-S., Cai, Q., Liu, J., Chen, X., & Yao, Z. (2009) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-009-9473-4 · Cited by 50 · see citing works
“5 in the midbrain/hindbrain junction, suggesting that a-SYN may play a yet undefined role in early brain development. a-SYN is reported to regulate DA synthesis by binding to and inhibiting tyrosine hydroxylase (TH) (Peng et al. 2005; Alerte et al. 2008).”
BackgroundNakashima, A., Ota, A., Kaneko, Y. S., Mori, K., Nagasaki, H., & Nagatsu, T. (2012) · Journal of Neural Transmission · doi:10.1007/s00702-012-0828-5 · Cited by 47 · see citing works
Advances in the development of imaging probes and aggregation inhibitors for alpha-synuclein
Xu, M., Ryan, P., Rudrawar, S., Quinn, R. J., Zhang, H., & Mellick, G. D. (2019) · Acta Pharmacologica Sinica · doi:10.1038/s41401-019-0304-y · Cited by 48 · see citing works
“In addition to its role in synaptic transmission, α-syn is also involved in the suppression of apoptosis [39], antioxidation [40] and even regulation of dopamine biosynthesis [41, 42].”
BackgroundTaymans, J., & Baekelandt, V. (2014) · Frontiers in Genetics · doi:10.3389/fgene.2014.00382 · Cited by 47 · see citing works
Expression of α-synuclein is increased in the hippocampus of rats with high levels of innate anxiety
Chiavegatto, S., Izídio, G. S., Mendes-Lana, A., Aneas, I., Freitas, T. A., Torrão, A. D. S., Conceição, I. M., Britto, L. R., & Ramos, A. (2008) · Molecular Psychiatry · doi:10.1038/mp.2008.43 · Cited by 46 · see citing works
Chen, L., Huang, E., Wang, H., Qiu, P., & Liu, C. (2013) · Brain Research · doi:10.1016/j.brainres.2013.05.016 · Cited by 44 · see citing works
Nematullah, M., Hoda, M. N., & Khan, F. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0444-3 · Cited by 42 · see citing works
“rat) cells leads to enhanced PP2A activation [105].”
BackgroundKlongpanichapak, S., Phansuwan‐Pujito, P., Ebadi, M., & Govitrapong, P. (2008) · Neuroscience Letters · doi:10.1016/j.neulet.2008.03.053 · Cited by 41 · see citing works
Vidal-Martínez, G., Najera, K., Miranda, J. D., Gil-Tommee, C., Yang, B. C., Vargas‐Medrano, J., Diaz-Pacheco, V., & Perez, R. G. (2019) · Neuroscience · doi:10.1016/j.neuroscience.2019.05.029 · Cited by 41 · see citing works
“…often contain Lewy Bodies, inclusions with abundant aSyn, a presynaptic protein that broadly contributes to dopamine regulation (Perez et al., 2002; Perez and Hastings, 2004; Peng et al., 2005; Tehranian et al., 2006; Porras and Perez, 2014; Benskey et al., 2016; Mor and Ischiropoulos, 2018).”
BackgroundSelf-citationKovaleski, R. F., Callahan, J. W., Chazalon, M., Wokosin, D. L., Baufreton, J., & Bevan, M. D. (2020) · The Journal of Physiology · doi:10.1113/jp279232 · Cited by 42 · see citing works
“…detection of tyrosine hydroxylase (TH; 1:500 mouse anti-TH; MAB318, RRID:AB 2201528; MilliporeSigma; Charalampopoulos et al. 2005; Peng et al. 2005; 1:250 Alexa Fluor 488 donkey anti-mouse IgG; 715-545-152, RRID: AB 2313584; Jackson Immunoresearch) and expression was quantified,…”
BackgroundLack of involvement of alpha-synuclein in unconditioned anxiety in mice
Peña‐Oliver, Y., Buchman, V. L., & Stephens, D. (2010) · Behavioural Brain Research · doi:10.1016/j.bbr.2010.01.049 · Cited by 39 · see citing works
“Alpha-synuclein down-regulates dopamine transmission by inhibiting the activity of tyrosine hydroxylase, decreasing dopamine synthesis and acting as a negative regulator of DA release (Peng et al., 2005; Perez et al., 2002).”
Ren, Q., Jiang, X. J., Paudel, Y. N., Gao, X., Gao, D., Zhang, P., Sheng, W., Shang, X., Liu, K., Zhang, X., et al. (2022) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2022.115234 · Cited by 38 · see citing works
Yang, W., Wang, X., Duan, C., Lu, L., & Yang, H. (2013) · Neurochemistry International · doi:10.1016/j.neuint.2013.06.010 · Cited by 38 · see citing works
- Authors
- Peng, X. M., Tehranian, R., Dietrich, P., Stefanis, L., & Perez, R. G.
- Affiliations
- University of Pittsburgh (US)
- Columbia University (US)
- Venue
- Journal of Cell Science
- Publisher
- The Company of Biologists
- Published
- 2005-08-01
- Volume
- 118
- Issue
- 15
- Pages
- 3523-3530
- ISSN
- 0021-9533 (ISSN-L)
- 1477-9137
- OpenAlex
- W2077584190
- Cited by
- 249
- References
- 52
- Citations by year
- 2026: 4 · 2025: 3 · 2024: 13 · 2023: 11 · 2022: 12 · 2021: 16 · 2020: 18 · 2019: 18 · 2018: 13 · 2017: 16 · 2016: 8 · 2015: 7 · 2014: 13 · 2013: 13 · 2012: 21
- FWCI
- 4.75
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Cell Science (publishedVersion)
- PubMed (publishedVersion)
- HighWire Press Open Archive (submittedVersion)
- Funders
- National Institute of Neurological Disorders and Stroke (NS42094, R01NS042094)
- Topics
- Health Sciences › Medicine › Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Nuclear Receptors and Signaling
- Health Sciences › Medicine › Neurology › Neurological disorders and treatments
- Keywords
- alpha-synuclein, protein phosphatase 2A, tyrosine hydroxylase, tyrosine hydroxylase phosphorylation, dopamine synthesis, dopaminergic neurons, protein kinase A, protein dephosphorylation, Parkinson's disease, protein-protein interaction
- MeSH terms
- Animals, Cell Line, Dopamine, Gene Expression Regulation, Mice, Inbred C57BL, Phosphoprotein Phosphatases, Phosphorylation, Serine, Tyrosine 3-Monooxygenase, PC12 Cells, Okadaic Acid, Mice, Rats, Protein Phosphatase 2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review